Conducting a COVID-19 drug and vaccine clinical trial

Conducting a COVID-19 drug and vaccine clinical trial Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19. 2021-06-30 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemicclinical trialsdrugsvaccineapply for a trial authorizationMedical Devices Regulationsinterim order for clinical trials for drug and vaccine related to COVID-19 Conducting a COVID-19 drug and vaccine clinical trialHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/conducting-clinical-trial.html Conducting a COVID-19 drug and vaccine clinical trialHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/liste-essais-cliniques-autorise.html

Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.

Data and Resources

Similar records